A noninvasive therapy delivering gentle spinal stimulation was shown to slow disease progression and extend survival in an ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson's disease and a way to modify it, paving the way for future treatments ...

Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her disease in its tracks.

The FDA approved a new drug Tuesday aimed at helping people with a rare form of ALS, which is about 2% of all patients.

The antioxidant, superoxide dismutase or SOD1, improves cognition by fighting off free radicals that cause oxidative damage in the brain. However, an Iowa State University research team found SOD1’s ...

The assay depends on mutant SOD1 to start and maintain propagation, but in other presentations Pokrishevsky and Cashman explained how wild-type SOD1 might also propagate as a prion. This may be ...

The decision on the SOD1 ALS program does not impact Voyager’s other gene therapy programs; the Company continues to expect IND filings in 2025 from Neurocrine Biosciences for the program in ...